Dosing and Administration

ERLEADA®: once-daily oral dosing1

A photo of 4 tan pills, they have A R 60 on them

Tablets shown are not actual size.

The recommended dose of ERLEADA® is 240 mg (four 60 mg tablets) administered  orally once daily 1

Patients should also receive a GnRH analog concurrently or should have had a bilateral orchiectomy.1

An icon of a blue pill container with a no symbol over it

No need for
co-administration of a corticosteroid.1

A blue knife and fork icon inside of a white circle

Can be taken with or without food. Tablets should be swallowed whole.1

An icon of a blue pill with arrows pointing up and down overlapped by the no symbol

No initial dose adjustments for ERLEADA® are necessary for renal or hepatic impairment.*1

*ERLEADA® has not been evaluated in patients with severe renal or hepatic impairment.

Dose Modifications

If a patient experiences a ≥Grade 3 toxicity or an intolerable side effect, hold dosing until symptoms improve to ≤Grade 1 or original grade, and then resume at the same dose or a reduced dose (180 mg or 120 mg), if warranted.1

GnRH = gonadotropin-releasing hormone.

Reference

1. ERLEADA® [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.